Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OncoMed Pharmaceuticals
company
About
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $154M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Aug 1, 2004
- Number Of Employee
- 51 - 100
- Operating Status
- Active
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cellsâ€. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$154M
OncoMed Pharmaceuticals has raised a total of
$154M
in funding over 2 rounds. Their latest funding was raised on
Nov 4, 2008 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 4, 2008 | Series B | $154M | 1 |
Phase4 Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
OncoMed Pharmaceuticals has made 1 investments. Their most recent investment was on
Mar 22, 2010, when ERPLY raised $2M.
Investors
Number of Lead Investors
Number of Investors
1
1
OncoMed Pharmaceuticals is funded by 1 investors.
Phase4 Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Phase4 Ventures
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
